"I love Frontpage - Danish Medicines Agency"

2022-05-20 14:42:02

Licensing and supervision Brexit Licensing of medicines Authorisation procedures Company authorisations and registrations Supervision and inspection Clinical trials How to evaluate evidence of the efficacy of medicines Evaluation of reviews Report suspected illegal activities Falsified medicines Compassionate use Medicine or not Export certificates Fees Name/address changes Relationships Financial support Medicinal Products Committee Publications Side effects and product information Side effects of medicines Additional monitoring News on pharmacovigilance Biological and biosimilar medicinal products Safety updates Direct Healthcare Professional Communication Adverse events Drug interaction Pharmacovigilance Council Find medicines Publications Reimbursement and prices General reimbursement Individual reimbursement Calculate reimbursement Medicines bought in another EU/EEA country Reimbursement Committee Prices of medicines Product numbers Central Reimbursement Register Reimbursable nutritional products Publications Pharmacies and sale of medicines Pharmacies Sale outside pharmacies Over-the-counter medicines Substitution Medicines imported from abroad Buying and selling medicines online Sale of medicines or food supplements online Doctors buying medicines for use in their own practices Report suspected illegal sale of medicines Prescriptions from another country Publications Medical devices New regulations COVID-19 antigen test for self-test Advice to consumers on buying face masks New Tech – new technological possibilities and medical devices Patient safety and safe medical devices Development of medical devices CE marking Incident reporting Notified bodies Registration and marketing Clinical investigations Certificates of Free Sale Legislation and guidance Publications Special product areas Veterinary medicines Natural medicinal products and vitamin and mineral products Euphoriant substances Medical gases Radiopharmaceuticals Medicines affecting the ability to drive Medicinal cannabis About us Mission, vision and strategy Contact Organisation Whistleblowing scheme of the Danish Medicines Agency Management of conflicts of interest Transparency in the Danish Medicines Agency Data protection policy Targets and tasks Activities in the EU and the rest of the world Jobs Digital services About this site Social media Design Campaigns Copyright Cookies Publications Sitemap News Subscribe to news Edit subscription Unsubscribe News categories Themes Our newsletter DKMA Update RSS Feed Publications Order publications 2022 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Go to main content News About us Publications Cookies Licensing and supervision Licensing and supervision Brexit Licensing of medicines Authorisation procedures Company authorisations and registrations Supervision and inspection Clinical trials How to evaluate evidence of the efficacy of medicines Evaluation of reviews Report suspected illegal activities Falsified medicines Compassionate use Medicine or not Export certificates Fees Name/address changes Relationships Financial support Medicinal Products Committee Publications Side effects and product information Side effects and product information Side effects of medicines Additional monitoring News on pharmacovigilance Biological and biosimilar medicinal products Safety updates Direct Healthcare Professional Communication Adverse events Drug interaction Pharmacovigilance Council Find medicines Publications Reimbursement and prices Reimbursement and prices General reimbursement Individual reimbursement Calculate reimbursement Medicines bought in another EU/EEA country Reimbursement Committee Prices of medicines Product numbers Central Reimbursement Register Reimbursable nutritional products Publications Pharmacies and sale of medicines Pharmacies and sale of medicines Pharmacies Sale outside pharmacies Over-the-counter medicines Substitution Medicines imported from abroad Buying and selling medicines online Sale of medicines or food supplements online Doctors buying medicines for use in their own practices Report suspected illegal sale of medicines Prescriptions from another country Publications Medical devices Medical devices New regulations COVID-19 antigen test for self-test Advice to consumers on buying face masks New Tech – new technological possibilities and medical devices Patient safety and safe medical devices Development of medical devices CE marking Incident reporting Notified bodies Registration and marketing Clinical investigations Certificates of Free Sale Legislation and guidance Publications Special product areas Special product areas Veterinary medicines Natural medicinal products and vitamin and mineral products Euphoriant substances Medical gases Radiopharmaceuticals Medicines affecting the ability to drive Medicinal cannabis What are you looking for? For example, reimbursement, cannabis or side effects Theme New strategy for the DKMA The Danish Medicines Agency has formulated a new strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more. Go to theme Theme Vaccines for children In July 2021, the first corona vaccine was introduced in Denmark for children aged 12-15 years. The EU Commission has also approved the vaccine for the smaller children aged 5-11 years. Read about the difference between vaccines for children and adults, and how the authorisation takes place. Go to theme General public Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public. Industry Information on licensing, inspections, fees, company authorisations, clinical trials and more. Healthcare professionals This section gathers information for doctors, nurses, pharmacies, dentists and other healthcare professionals. Report a side effect from medicines About Brexit International activities Transparency Subscribe to news in English Mission, vision and strategy Telephone directory Whistleblower scheme Jobs 0 News New executive order raises fees in the area of the Danish Medicines Agency 03 May 2022 Higher fees become payable for medicinal products and pharmaceutical companies as a result of a new executive order entering into force on 1 May 2022. The last time the fees were adjusted was in 2017. Danish Medicines Agency presents new strategy 05 April 2022 2021 deadline for submitting applications concerning marketing authorisations and clinical trials 08 November 2021 Danish Medicines Agency investigates a case of inflammatory condition reported after COVID-19 vaccination 26 August 2021 See all news items Subscribe Latest updated content Danish Medicines AgencyAxel Heides Gade 12300 København SEmail:[email protected] Contact the Danish Medicines Agency +45 44 88 95 95 (9am - 3pm) Contact DKMAnet +45 44 88 96 94 Follow us CVR-nr. 37 05 24 85 EAN 5798 000 36 33 66 Cookie policy